Viracta Therapeutics (VIRX) Q3 2023 Earnings

9NovConfirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-0.38
-0.34
-0.31
-0.27

Details

Expected EPS
-0.3
Actual EPS
-0.33
Surprise EPS
-0.03
Surprise Percent
+10%

Description

Viracta Therapeutics (VIRX) has reported earnings of -0.33 per share for Q3 2023.

0 Comments

Share your thoughts